Maryland State Retirement & Pension System increased its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 27.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,737 shares of the medical instruments supplier’s stock after buying an additional 4,264 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Becton, Dickinson and Company were worth $3,533,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Becton, Dickinson and Company during the 2nd quarter valued at $3,721,533,000. State Street Corp boosted its position in Becton, Dickinson and Company by 8.5% during the 2nd quarter. State Street Corp now owns 15,000,064 shares of the medical instruments supplier’s stock worth $2,269,960,000 after acquiring an additional 1,177,256 shares during the period. First Eagle Investment Management LLC grew its stake in shares of Becton, Dickinson and Company by 15.8% in the second quarter. First Eagle Investment Management LLC now owns 13,815,335 shares of the medical instruments supplier’s stock worth $2,090,675,000 after purchasing an additional 1,887,224 shares in the last quarter. Bank of America Corp DE bought a new position in shares of Becton, Dickinson and Company in the second quarter worth $474,993,000. Finally, Legal & General Group Plc increased its holdings in shares of Becton, Dickinson and Company by 1.5% during the second quarter. Legal & General Group Plc now owns 2,101,695 shares of the medical instruments supplier’s stock valued at $318,050,000 after purchasing an additional 30,766 shares during the period. 86.97% of the stock is currently owned by institutional investors and hedge funds.
Becton, Dickinson and Company Stock Down 0.0%
BDX stock opened at $217.95 on Monday. The firm has a market cap of $60.05 billion, a PE ratio of 52.64, a P/E/G ratio of 3.65 and a beta of 0.22. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.87 and a quick ratio of 0.54. The firm has a 50 day simple moving average of $190.90 and a 200 day simple moving average of $170.56. Becton, Dickinson and Company has a 12 month low of $140.11 and a 12 month high of $219.78.
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last issued its earnings results on Thursday, November 5th. The medical instruments supplier reported $4.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.07 by $0.08. The business had revenue of $5.27 billion for the quarter, compared to analysts’ expectations of $5.11 billion. Becton, Dickinson and Company had a return on equity of 14.90% and a net margin of 5.66%. The company’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the firm posted $3.96 EPS. Equities research analysts forecast that Becton, Dickinson and Company will post 13.21 earnings per share for the current fiscal year.
Becton, Dickinson and Company Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Thursday, December 10th will be paid a dividend of $1.06 per share. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $1.05. The ex-dividend date of this dividend is Thursday, December 10th. This represents a $4.24 annualized dividend and a yield of 1.9%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is presently 101.45%.
Becton, Dickinson and Company announced that its board has initiated a share buyback plan on Thursday, November 5th that allows the company to repurchase 10,000,000 shares. This repurchase authorization allows the medical instruments supplier to repurchase up to 3.6% of its shares through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.
Analysts Set New Price Targets
A number of research analysts have recently commented on BDX shares. Weiss Ratings upgraded shares of Becton, Dickinson and Company from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, November 4th. UBS Group began coverage on shares of Becton, Dickinson and Company in a report on Tuesday, July 28th. They issued a “buy” rating and a $190.00 price objective for the company. JPMorgan Chase & Co. increased their target price on shares of Becton, Dickinson and Company from $170.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, November 6th. Stifel Nicolaus set a $195.00 target price on shares of Becton, Dickinson and Company in a research note on Friday, August 7th. Finally, Royal Bank Of Canada raised their target price on shares of Becton, Dickinson and Company from $190.00 to $225.00 and gave the company a “sector perform” rating in a research note on Friday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $197.47.
Read Our Latest Report on Becton, Dickinson and Company
Insider Buying and Selling at Becton, Dickinson and Company
In other Becton, Dickinson and Company news, EVP Michael Feld sold 165 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $188.49, for a total value of $31,100.85. Following the completion of the sale, the executive vice president owned 19,720 shares in the company, valued at $3,717,022.80. This represents a 0.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Thomas E. Polen, Jr. sold 2,993 shares of the stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $210.00, for a total value of $628,530.00. Following the sale, the chief executive officer owned 110,163 shares of the company’s stock, valued at approximately $23,134,230. This represents a 2.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 3,310 shares of company stock worth $688,650 over the last three months. 0.40% of the stock is owned by insiders.
Becton, Dickinson and Company Company Profile
Becton, Dickinson and Company, commonly known as BD, is a global medical technology company that develops and manufactures products used in healthcare, clinical laboratories and life sciences research. Founded in 1897, the company has a long history of producing medical devices and supplies. BD’s products include syringes, needles, infusion systems and medication-management technologies, as well as equipment and supplies for collecting and processing clinical specimens. The company also provides diagnostic systems, laboratory instruments and tools used in areas such as cell analysis and biomedical research.
See Also
- Five stocks we like better than Becton, Dickinson and Company
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX – Free Report).
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.
